David Bulteel
“March completed a shaky first quarter for the markets. Continued concerns with issues such as the credit markets, corporate profits, economic growth and consumer sentiment continued to dent confidence, although all equity funds ended March at higher levels than were plumbed mid-month. The higher beta areas such as Emerging Markets (JP Morgan) and Japanese Smaller Cos (Atlantis) suffered but we remain comfortable with both managers and long term prospects for the respective asset classes. Dexion Absolute, a listed fund of hedge funds suffered from discount widening or, strictly speaking, a partial loss of its premium rating.”
AMOUNT (E) FUND
15,000 Fidelity European Bond Fund
15,000 Thames River Euro Global Bond Fund
10,000 Artemis European Growth Fund
10,000 Fidelity European Equity Fund
10,000 Gartmore Continental European Equity
8,000 Schroder European Alpha Plus
5,000 Dexion Absolute Fund of Hedge Funds
5,000 Threadneedle Euro High Yield Bond Fund
3,500 Polar Capital Japan Fund
3,000 European Asset Value Fund
3,000 Merrill Lynch US Flexible Equity Fund
3,000 Schroder UK Alpha Plus
3,000 UBS US Equity Fund
2,000 Findlay Park US Smaller Cos
1,500 Atlantis Japan Growth Fund
1,500 JP Morgan Emerging Markets Equity Fund
1,500 Threadneedle Asia Fund
